Yonkers, N.Y. – St. John’s Riverside Hospital is proud to announce the availability of DaTscan™, the first FDA-approved imaging agent to help physicians evaluate patients with suspected Parkinson’s disease (PD). DaTscan gives physicians the ability to diagnose in a more timely fashion that in turn may lead to a more appropriate diagnosis and treatment.